Showing 1 - 10 of 9,110
Persistent link: https://www.econbiz.de/10011900045
provinces became the ultimate paymasters for health-care personnel. The natural result was an ongoing competition between …
Persistent link: https://www.econbiz.de/10014155102
markets (US, UK, Canada, Germany) but that regulation undermines generic competition in strict regulatory systems (France …, Italy, Japan). Regulation of retail pharmacy further constrains competition in France, Germany and Italy. Regulation thus …Most countries regulate pharmaceutical prices, either directly or indirectly, on the assumption that competition is at …
Persistent link: https://www.econbiz.de/10014038394
of the patent system and related forms of protection than has previously been recognised. Nevertheless, the rate of … patent protection, an exclusion whose history has produced a substantial body of scholarship. However, its aims go beyond …
Persistent link: https://www.econbiz.de/10014100043
This short paper identifies an insidious pattern in the United States (US) pharmaceutical industry: while drug prices are skyrocketing, insurers are perfectly shielding patients from higher costs at the pharmacy checkout, letting patients live in a "bubble" of price insulation. As drug prices...
Persistent link: https://www.econbiz.de/10014347941
In light of the stakes involved, greater attention is being directed to the global effort to combat pharmaceutical counterfeiting, and both public and private actors are being called to the fight. The counterfeiting of medical products remains a prominent obstacle to a fully effective health...
Persistent link: https://www.econbiz.de/10014191006
Persistent link: https://www.econbiz.de/10001486392